Datwyler is able to make an important contribution to the global fight against the pandemic with its system-critical elastomer components. The company is supporting the leading pharmaceutical companies in the provision of COVID-19 vaccines.
Stefan Sevens, VP Medical at Datwyler, talks about maximizing performance, comfort, and durability of wearable devices.
In an interview with the Swiss online portal «The Market», Datwyler CEO Dirk Lambrecht explains the potential of Healthcare Solutions and Food & Beverage, and explains why e-cars are not a disadvantage for Datwyler.
Datwyler's Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, shares key learnings since the launch of Datwyler's NeoFlex™ plungers at the start of the COVID-19 pandemic.
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how ‘Quality-by-design’ enables drug efficacy & minimises contamination.
Datwyler’s Senior Vice President of Pharma, Glenn Thorpe, discusses the evolution of the parenteral drug market and how parenteral packaging is meeting these ever-changing challenges.
Navigating pharma’s packaging challenges amid a pandemic.
Datwyler discusses five considerations for drug manufacturers to consider when selecting parenteral packaging for their drug products.
Datwyler’s Senior Vice President of Pharma, Glenn Thorpe, discusses the evolution of the parenteral drug market and how parenteral packaging is meeting these ever-changing challenges.
Glenn Thorpe, Senior Vice President, Pharma at Datwyler, says pharmaceutical companies should engage with packaging suppliers that can meet the industry demands of the pandemic.
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.
In Korean publication, Plastic Net, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
Dirk Borghs considers the obligation of the pharmaceutical sector to implement environmentally responsible practices, and discusses the steps Datwyler is taking in its efforts for sustainability.
In Korean Packaging Association, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
In May, Project Jumpstart, a public-private initiative, was announced that will pump $138 million into the production of 100 million prefilled syringes by the end of this year and another 500 million in 2021, should a COVID-19 vaccine become available. Yet, industry gurus do not necessarily agree that the pandemic will have a positive impact on the injection delivery market. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the important role that coated plungers play in ensuring the appropriate functionality and compatibility of injection devices.
When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
Carina Van Eester explores the benefits of fully coated plungers for prefilled syringes and cartridges.
Plunger Designed with Functionality in Mind.
The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.
Rahul Thakar, PhD, technical key account manager at Datwyler Pharma, discusses the rise of injectables, quality control measures, and personalization.
Datwyler has launched its NeoFlex plungers to help developers better protect the integrity of injectable formulations and optimise the functionality of prefilled syringes and cartridge.
Container closure integrity (CCI) is an increasingly relevant issue in the pharmaceutical packaging industry. It addresses the maintenance of integrity to prevent microbial ingress in sterile product packaging until the time of use, as well as to restrict the loss of product contents and to prevent the entry of detrimental gases or other materials.
With the advent of biologics and highly sensitive drugs, primary packaging materials must meet the highest-level of functional, regulatory and cleanliness standards to ensure compatibility and ultimately, patient safety. Rahul Thakar, PhD, discusses Datwyler's solution to these ever-stricter requirements is their highest-quality manufacturing standard, FristLine™.
